🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This cancer vaccine research study involves the injection of the NY-ESO-1b ...
Status
Completed
Location
Krankenhaus Nordwest
Start Date
2003-09-03
Trial ID
NCT00199836
Treatments Being Tested
The purpose of this study is assess the safety of administering repeated do...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2011-05
Trial ID
NCT01234012
Treatments Being Tested
The incidence of melanoma is increasing with an estimated incidence of 59,9...
Status
Completed
Location
New York University Langone Medical Center
Start Date
2010-09
Trial ID
NCT01079741
Treatments Being Tested
This is an open-label, multicenter, 2-arm study to evaluate the safety and ...
Status
Completed
Location
Research Facility
Start Date
2017-12-20
Trial ID
NCT03164772
Treatments Being Tested
RATIONALE: Vaccines made from peptides may make the body build an immune re...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2003-10-28
Trial ID
NCT00070070
Treatments Being Tested
The hope is that the peptide vaccines will stimulate the immune system to a...
Status
Completed
Location
University of Arkansas for Medical Sciences/MIRT
Start Date
2004-06
Trial ID
NCT00090493
Treatments Being Tested
To evaluate the safety of NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine gi...
Status
Completed
Location
New York Presbyterian Hospital
Start Date
2004-09-27
Trial ID
NCT00199849
Treatments Being Tested
This pilot phase I trial studies the side effects of taking ipilimumab afte...
Status
Terminated
Location
Jonsson Comprehensive Cancer Center
Start Date
2014-07-17
Trial ID
NCT02070406
This clinical trial is looking at two new vaccines called ChAdOx1-MAGEA3-NY...
Status
Suspended
Location
Blackpool Victoria Hospital
Start Date
2021-10-15
Trial ID
NCT04908111
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as cyclophosphamide and fludara...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
2004-01
Trial ID
NCT00079144